$rIONS
Pioneer and leader in RNA-targeted therapeutics, developing antisense medicine for rare diseases.
$498.69
▼86.77%from 30d ago
$43.91
▼4.02%from 30d ago
2
▲+100.00%from 30d ago
$13.56K
▲+256.96%from 30d ago
Ionis Pharmaceuticals, Inc. Reality Metrics
Metric
Show % of Total
Key Facts
Name
Ionis Pharmaceuticals, Inc. Reality
Ticker
rIONS
CUSIP
—
ISIN
—
Platform
Tokenization
Type
Type
Tokenization Sponsorship
Third-Party
Type
—
Asset Manager
—
Asset Class
Underlying Security
Eligible Investors
Inception Date
01/01/2026
Use Of Income
—
Management
Fees
Fees
0%
Performance
Fees
Fees
0%
Market Data
Total Value
$499
▲
NAV
$43.91
Price
—
Token Supply
11.36
▼
Circulating Supply
11.36
▼
7D APY
—
30D APY
—
Holders
2
▲
Trailing 30D
Active Addresses
Active Addresses
4
▲
Monthly
Transfer Count
Transfer Count
11
▲
Monthly
Transfer Volume
Transfer Volume
$13,557
▲
Tokens
Primary Market
Eligible Investors
Non-U.S. Investor
Base Assets
USDCUSDT
Subscription Time
Instant
Min.
Investment
Investment
20 USDC
Subscription
Fees
Fees
0.10%
Subscription Description
—
Redemption Time
Instant
Minimum Redemption Amount
0 USDC
Redemption
Fees
Fees
0.10%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Asset Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
Alpaca Securities LLC
0001702580Crypto Custodian
—
Fund Administrator
—
Traditional Broker
Crypto Broker
—
Auditor
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
BG El Salvador
Issuer LEI
—
Issuer CIK
—
Domicile
El Salvador
Regulatory Framework
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account
Segregation
Segregation
Bankruptcy
Remote
Remote
Deposit
Insurance
Insurance
Fees
Management
Fees
Fees
0%
Performance
Fees
Fees
0%
Other Fees
—
Redemption
Fees
Fees
0.10%
Subscription
Fees
Fees
0.10%
Holders
View detailed token
holder breakdowns
Sign up for a free account to get access to breakdowns of which investor addresses hold an RWA across blockchain networks.
Holders Product Screenshot
RWA.xyzAll Rights Reserved